VIVO's free cash flow for Q was $-1.49M. For the fiscal year, VIVO's free cash flow was decreased by $25.19M and operating cash flow was $1.99M. See a summary of the company’s cash flow.

Cash Flow	TTM	Sep 22	Sep 21	Sep 20	Sep 19	Sep 18
Operating Cash Flow	$ 82.36M	$ 82.36M	$ 66.86M	$ 47.98M	$ 36.17M	$ 34.79M
Investing Cash Flow	$ -11.12M	$ -11.12M	$ -40.40M	$ -54.60M	$ -48.45M	$ -4.20M
Financing Cash Flow	$ -34.30M	$ -34.30M	$ -31.07M	$ -3.56M	$ 14.92M	$ -27.60M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 314.16M	$ 81.45M	$ 49.77M	$ 53.51M	$ 62.40M	$ 60.76M
Income Tax Paid Supplemental Data	-	$ 26.82M	$ 27.47M	$ 9.82M	-	$ 6.55M
Interest Paid Supplemental Data	-	$ 934.00K	$ 1.35M	$ 2.69M	$ 1.41M	$ 1.49M
Issuance Of Capital Stock	-	-	-	-	-	-
Issuance Of Debt	-	$ 0.00	$ 10.00M	$ 50.00M	$ 75.82M	$ 0.00
Repayment Of Debt	$ -35.00M	$ -35.00M	$ -18.82M	$ -57.00M	$ -50.25M	$ -4.50M
Free Cash Flow	$ 73.75M	$ 73.75M	$ 48.55M	$ 44.68M	$ 32.38M	$ 30.59M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Meridian Bioscience Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing